Search

Author/Creator Palenzuela-Díaz, Ariel

1. Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children. (January 2023)

Authors:
Puga-Gómez, Rinaldo; Ricardo-Delgado, Yariset; Rojas-Iriarte, Chaumey; Céspedes-Henriquez, Leyanis; Piedra-Bello, Misleidys; Vega-Mendoza, Dania; Pérez, Noelvia Pestana; Paredes-Moreno, Beatriz; Rodríguez-González, Meiby; Valenzuela-Silva, Carmen; Sánchez-Ramírez, Belinda; Rodríguez-Noda, Laura; ...
Journal:
International journal of infectious diseases
Issue:
Volume 126(2023)
Page Start:
164
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials. Issue 31 (29th July 2022)

Authors:
Eugenia-Toledo-Romaní, María; Verdecia-Sánchez, Leslyhana; Rodríguez-González, Meiby; Rodríguez-Noda, Laura; Valenzuela-Silva, Carmen; Paredes-Moreno, Beatriz; Sánchez-Ramírez, Belinda; Pérez-Nicado, Rocmira; González-Mugica, Raul; Hernández-García, Tays; Bergado-Baez, Gretchen; Pi-Estopiñán, Fra...
Journal:
Vaccine
Issue:
Volume 40:Issue 31(2022)
Page Start:
4220
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial. Issue 8 (August 2022)

Authors:
Ochoa-Azze, Rolando; Chang-Monteagudo, Arturo; Climent-Ruiz, Yanet; Macías-Abraham, Consuelo; Valenzuela-Silva, Carmen; de los Ángeles García-García, María; Jerez-Barceló, Yanet; Triana-Marrero, Yenisey; Ruiz-Villegas, Laura; Dairon Rodríguez-Prieto, Luis; Guerra-Chaviano, Pedro Pablo; Sánchez-Ra...
Journal:
Lancet
Issue:
Volume 10:Issue 8(2022)
Page Start:
785
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study). (April 2022)

Authors:
Hernández-Bernal, Francisco; Ricardo-Cobas, Maria C.; Martín-Bauta, Yenima; Navarro-Rodríguez, Zadis; Piñera-Martínez, Marjoris; Quintana-Guerra, Joel; Urrutia-Pérez, Karen; Urrutia-Pérez, Klaudia; Chávez-Chong, Cristina O.; Azor-Hernández, Jorge L.; Rodríguez-Reinoso, José L.; Lobaina-Lambert, L...
Journal:
EClinicalMedicine
Issue:
Volume 46(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗